Zhongping Tang

582 total citations
12 papers, 494 citations indexed

About

Zhongping Tang is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Zhongping Tang has authored 12 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Zhongping Tang's work include Peptidase Inhibition and Analysis (4 papers), Cancer Mechanisms and Therapy (3 papers) and Ubiquitin and proteasome pathways (2 papers). Zhongping Tang is often cited by papers focused on Peptidase Inhibition and Analysis (4 papers), Cancer Mechanisms and Therapy (3 papers) and Ubiquitin and proteasome pathways (2 papers). Zhongping Tang collaborates with scholars based in China, United States and Germany. Zhongping Tang's co-authors include Enhua Wang, Qianze Dong, Zixuan Li, Lin Fu, Xin-Jun Dong, Yang Wang, Qingchang Li, Ying Xu, Haiying Li and Yang Wang and has published in prestigious journals such as PLoS ONE, American Journal Of Pathology and Journal of Histochemistry & Cytochemistry.

In The Last Decade

Zhongping Tang

12 papers receiving 491 citations

Peers

Zhongping Tang
Jincai Wu China
Yingqiu Y. Liu United States
Sylvia Mahara Singapore
Anup Sharma United States
Zhongping Tang
Citations per year, relative to Zhongping Tang Zhongping Tang (= 1×) peers María Villa‐Morales

Countries citing papers authored by Zhongping Tang

Since Specialization
Citations

This map shows the geographic impact of Zhongping Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongping Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongping Tang more than expected).

Fields of papers citing papers by Zhongping Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongping Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongping Tang. The network helps show where Zhongping Tang may publish in the future.

Co-authorship network of co-authors of Zhongping Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongping Tang. A scholar is included among the top collaborators of Zhongping Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongping Tang. Zhongping Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Sun, Yu, et al.. (2019). Microneedle fractional radiofrequency treatment of facial photoageing as assessed in a split‐face model. Clinical and Experimental Dermatology. 44(4). e96–e102. 15 indexed citations
2.
Ma, Xiaojuan, et al.. (2018). Ultrasonography findings of proximal‑type epithelioid sarcoma of the vulva: A case report. Molecular and Clinical Oncology. 9(5). 507–510. 2 indexed citations
3.
Tang, Zhongping, et al.. (2017). TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer. Molecular Carcinogenesis. 57(2). 159–166. 20 indexed citations
4.
Li, Haiying, Liangliang Sun, Ying Xu, et al.. (2013). Overexpression of MTA3 Correlates with Tumor Progression in Non-Small Cell Lung Cancer. PLoS ONE. 8(6). e66679–e66679. 24 indexed citations
5.
Dong, Qianze, Yang Wang, Zhongping Tang, et al.. (2013). Derlin-1 Is Overexpressed in Non-Small Cell Lung Cancer and Promotes Cancer Cell Invasion via EGFR-ERK–Mediated Up-Regulation of MMP-2 and MMP-9. American Journal Of Pathology. 182(3). 954–964. 107 indexed citations
6.
Tang, Zhongping, et al.. (2013). Ataxia-Telangiectasia Group D Complementing Gene (ATDC) Promotes Lung Cancer Cell Proliferation by Activating NF-κB Pathway. PLoS ONE. 8(6). e63676–e63676. 21 indexed citations
8.
Tang, Zhongping, Xiupeng Zhang, Huanyu Zhao, et al.. (2013). Leucine Zipper Tumor Suppressor 2 Inhibits Cell Proliferation and Regulates Lef/Tcf-dependent Transcription through Akt/GSK3β Signaling Pathway in Lung Cancer. Journal of Histochemistry & Cytochemistry. 61(9). 659–670. 8 indexed citations
9.
Li, Haiying, Liangliang Sun, Zhongping Tang, et al.. (2012). Overexpression of TRIM24 Correlates with Tumor Progression in Non-Small Cell Lung Cancer. PLoS ONE. 7(5). e37657–e37657. 95 indexed citations
10.
Li, Zixuan, Qianze Dong, Bo Huang, et al.. (2012). Overexpression of CARMA3 in Non-Small-Cell Lung Cancer Is Linked for Tumor Progression. PLoS ONE. 7(5). e36903–e36903. 27 indexed citations
11.
Dong, Qianze, Yang Wang, Xin-Jun Dong, et al.. (2010). CIP2A is Overexpressed in Non-Small Cell Lung Cancer and Correlates with Poor Prognosis. Annals of Surgical Oncology. 18(3). 857–865. 136 indexed citations
12.
Liang, Xiao‐Huan, M. Stemler, Hans Will, et al.. (1988). Low incidence and high titers of antibodies to hepatitis B virus X‐Protein in sera of chinese patients with hepatocellular carcinoma. Journal of Medical Virology. 25(3). 329–337. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026